Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004579405 | SCV005068154 | pathogenic | Combined deficiency of sialidase AND beta galactosidase | 2024-01-12 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the CTSA gene has been identified. Loss-of-function variants in CTSA are known to be pathogenic (PMID: 15110321, 23915561). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals affected with CTSA-related conditions. For these reasons, this variant has been classified as Pathogenic. |